Literature DB >> 3264602

Evoked potentials and electroencephalography in adolescents with phenylketonuria.

R Korinthenberg1, K Ullrich, F Füllenkemper.   

Abstract

We studied the pattern-reversal VEP, the BAEP and the EEG with conventional and computerized analysis in 41 adolescents with hyperphenylalaninemia (24 HPA type 1, 12 HPA type 2, 4 HPA type 3, 1 DHPR deficiency) and 35 control persons. A prolongation of the P100 latency in the VEP, a greater interear difference of the I-V interwave latency in the BAEP and slowing of EEG background activity were found. Five per cent of the patients demonstrated spikes and 12.5% abnormal sharp transients in the EEG. The latency increase in the VEP corresponded to the compliance with the diet during the first decade of life. No influence of the actual Phe concentration at the time of the investigation was demonstrated. The BAEP- and EEG-findings were not related to the course of treatment. Thus the VEP changes in this cross sectional study refer to alterations of brain function that occurred during the early years of life. To investigate the value of evoked potentials and EEG in monitoring brain function after discontinuing the diet longitudinal data are needed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264602     DOI: 10.1055/s-2008-1052440

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  12 in total

Review 1.  Brain stem evoked potentials in childhood neurological diseases.

Authors:  R Kalmanchey
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability.

Authors:  A C Ludolph; U Vetter; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 3.  Late effects of phenylketonuria.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

4.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study.

Authors:  A M Paans; J Pruim; G P Smit; G Visser; A T Willemsen; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.

Authors:  S J Jones; G Turano; A Kriss; F Shawkat; B Kendall; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 7.  White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

Authors:  U Bick; K Ullrich; U Stöber; H Möller; G Schuierer; A C Ludolph; C Oberwittler; J Weglage; U Wendel
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

8.  Reduced macular thickness and macular vessel density in early-treated adult patients with PKU.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2021-05-05

9.  Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.

Authors:  Leo M J de Sonneville; Stephan C J Huijbregts; Robert Licht; Joseph A Sergeant; Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

Review 10.  Phenylketonuria: dietary and therapeutic challenges.

Authors:  M Giovannini; E Verduci; E Salvatici; L Fiori; E Riva
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.